ASH 2014: Phase II study of lenalidomide plus rituximab for mantle cell lymphoma (Part 2)
Jia Ruan • 5 Dec 2014
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter